Drugs / MSC 3P
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03838666 | Dec 2012 → Nov 2015 | rotator cuff syndrome | Bioinova, s.r.o. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC 3P | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03838666 ↗ |
| Modality | Cell therapy | “augmented by mesenchymal stem cells (MSCs)” NCT03838666 ↗ |
| Route | Other | “on the surface of the repaired rotator cuff tendon” NCT03838666 ↗ |